Indian Digoxin Exporters: Complete Supplier Ranking with Market Share — 293 Manufacturers (2026) — TransData Nexus

Q: Who is the largest digoxin buyer importing from India?

NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) is the largest digoxin importer from India with a 27.4% market share and import value of $597.5K.

Q: How many digoxin buyers import from India?

There are 293 active digoxin buyers importing from India, with a combined import market of $2.2M across 886 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top digoxin buyers from India?

The top 5 digoxin buyers — NORTHSTAR DISTRIBUTION CENTER 8912, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, JAMP PHARMA CORPORATION, NORTHSTAR DISTRIBUTION CENTER — together control 51.0% of total digoxin import value from India.

Suresh Sormare

Digoxin

India Pharmaceutical Trade Intelligence

$2.2M203 Suppliers104 CountriesHS 30049099

ExportsIndia → UNITED STATES51.4%India → SRI LANKA5.7%

ImportsGERMANY → India$83.2K UNITED STATES → India$12.2K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: NORTHSTAR DISTRIBUTION

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $1.1M through 61 shipments. This represents a market share of 51.4% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• NORTHSTAR DISTRIBUTION CENTER 8912 - $597.5K (53.3% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES,INC. - $259.1K (23.1% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES INC - $124.8K (11.1% of country's total business)

• NORTHSTAR DISTRIBUTION CENTER - $57.1K (5.1% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIESINC. - $54.5K (4.9% of country's total business)

• Rest of United States's importers - $27.3K (2.4% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $18.4K, indicating premium pricing strategy compared to the market average of $2.5K.

United States is a key market for Digoxin imports, representing 51.4% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Digoxin buyer market intelligence

1Buyer Segment Analysis

The importers of Digoxin from India can be categorized into several key segments:

1. Distributors: Entities such as NORTHSTAR DISTRIBUTION CENTER 8912 and SUN PHARMACEUTICAL INDUSTRIES, INC. in the United States fall into this category. These distributors typically procure large volumes to supply hospitals, pharmacies, and other healthcare providers. Their purchasing patterns are characterized by bulk orders and a focus on maintaining a consistent supply chain to meet market demand.

2. Contract Manufacturers: Companies like SUN PHARMACEUTICAL INDUSTRIES INC. in the United States often engage in contract manufacturing. They import Digoxin as an active pharmaceutical ingredient (API) for formulation and packaging under their brand names. Their procurement is driven by production schedules and market forecasts, leading to periodic, sizable orders.

3. Retail Chains: Entities such as JAMP PHARMA CORPORATION in Canada represent retail chains that import Digoxin to stock their pharmacy outlets. Their buying behavior is influenced by consumer demand, leading to regular, moderate-sized orders to ensure product availability without overstocking.

4. Government Procurement: Organizations like F.D.E.C.A in Ecuador and LEBOO HEALTHCARE PRODUCTS C.A in Venezuela are indicative of government procurement agencies. They often purchase Digoxin through tender-based systems to supply public healthcare facilities. Their orders are typically large and scheduled according to national healthcare needs and budget allocations.

5. Re-exporters: Companies such as ACTIVO INGREDINETS PTE LTD. in Singapore may act as re-exporters, importing Digoxin for distribution to neighboring countries. Their purchasing patterns are opportunistic, based on regional demand fluctuations and trade agreements.

Country-Specific Import Regulations

TransData Nexus Digoxin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process for Digoxin: Importers must ensure that Digoxin complies with FDA regulations, including proper labeling and registration. Affirmation of Compliance codes such as Drug Registration Number (REG), Drug Listing Number (DLS), and Drug Application Number (DA) are utilized to facilitate FDA review.

3. Estimated Timeline for Registration: The timeline varies based on compliance and documentation but can range from a few weeks to several months.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally subject to a 0% import duty in the United States.

Sri Lanka

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process for Digoxin: Importers must obtain prior approval from the NMRA, including product registration and import licensing.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and regulatory reviews.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally exempt from import duties in Sri Lanka.

Venezuela

1. Drug Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).

2. Import Registration Process for Digoxin: Requires product registration with INHRR, including submission of quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The process can take approximately 12 to 18 months, subject to regulatory assessments and potential delays.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products may be subject to import duties; however, specific rates can vary and should be confirmed with Venezuelan customs authorities.

Demand Drivers & Market Opportunity

TransData Nexus Digoxin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Digoxin in importing countries is primarily driven by the prevalence of cardiovascular diseases, particularly atrial fibrillation and heart failure, conditions for which Digoxin is a standard treatment. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2025. This high disease burden necessitates a steady supply of effective medications like Digoxin.

Government healthcare programs and the expansion of universal health coverage also significantly influence Digoxin demand. Many countries have incorporated Digoxin into their national essential medicines lists, aligning with the WHO Model List of Essential Medicines, which emphasizes the importance of such drugs in primary healthcare. Tender-based procurement systems are commonly employed by governments and international organizations to ensure the availability of essential medicines. For instance, the WHO's Disease Control Priorities initiative highlights the critical role of efficient procurement processes in maintaining drug supplies. The presence of 293 buyers across 104 countries, as per our data, underscores the global reliance on Digoxin and the opportunities for suppliers to meet this widespread demand.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Digoxin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest digoxin buyer importing from India?

Based on import volume and value, NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) leads with $597.5K in imports and a 27.4% market share — the highest of any single digoxin importer. SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES) and SUN PHARMACEUTICAL INDUSTRIES INC (UNITED STATES) are the next largest buyers.

QHow many companies buy digoxin from India?

There are 293 active digoxin buyers importing from India, with a combined market of $2.2M across 886 shipments to 104 countries. The top 5 buyers hold 51.0% of total import value, while the remaining 288 buyers handle the other 49.0%.

QWhich countries import the most digoxin from India?

The top importing countries for digoxin from India are United States (51.4%), Sri Lanka (5.7%), Venezuela (5.3%), Canada (4.4%), Nigeria (3.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of digoxin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for digoxin from India?

The average import transaction value for digoxin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Digoxin buyer market intelligence

1Buyer Segment Analysis

The importers of Digoxin from India can be categorized into several key segments:

Country-Specific Import Regulations

TransData Nexus Digoxin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The timeline varies based on compliance and documentation but can range from a few weeks to several months.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally subject to a 0% import duty in the United States.

Sri Lanka

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process for Digoxin: Importers must obtain prior approval from the NMRA, including product registration and import licensing.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and regulatory reviews.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally exempt from import duties in Sri Lanka.

Venezuela

1. Drug Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).

2. Import Registration Process for Digoxin: Requires product registration with INHRR, including submission of quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The process can take approximately 12 to 18 months, subject to regulatory assessments and potential delays.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products may be subject to import duties; however, specific rates can vary and should be confirmed with Venezuelan customs authorities.

Demand Drivers & Market Opportunity

TransData Nexus Digoxin buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Digoxin

Digoxin

Who Buys Digoxin from India — 293 Importers Behind a $2.2M Market

Top Digoxin Importers — Ranked by Import Value

Top Digoxin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Digoxin — and from which countries?

Digoxin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Digoxin Buyers & Importers

QWho is the largest digoxin buyer importing from India?

QHow many companies buy digoxin from India?

QWhich countries import the most digoxin from India?

QWhat is the average import order value for digoxin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Sri Lanka

3Venezuela

4Canada

5Nigeria

Analysis Methodology